Perfil
Christopher Rovaldi es Vicepresidente Senior de Gestión de Programas y Operaciones en Acceleron Pharma, Inc. Anteriormente, el Sr. Rovaldi ocupó el cargo de Director de Gestión de Proyectos en Idenix Pharmaceuticals LLC, de Investigador Asociado Senior de Periodontix, Inc. y de Director de Gestión de Proyectos en Cubist Pharmaceuticals LLC. Obtuvo un título de posgrado y una licenciatura en la Universidad de New Hampshire.
Antiguos cargos conocidos de Christopher Rovaldi.
| Empresas | Cargo | Fin |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Presidente | 18/08/2025 |
| ACCELERON PHARMA INC. | Director de Operaciones | 01/05/2018 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2007 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2004 |
Periodontix, Inc.
Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Corporate Officer/Principal | - |
Formación de Christopher Rovaldi.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Periodontix, Inc.
Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease | Commercial Services |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Rovaldi
















